What is mole mapping software?
Mole mapping software is a clinical tool used by dermatologists and skin clinics to record every lesion on a patient's body, link each to a dermoscopy or close-up image, and monitor change across visits. Modern systems pair traditional body mapping with AI-assisted screening, so reviewers can prioritise lesions that may warrant closer attention. ScanSkinAI is designed to fit inside an existing clinic workflow — not to replace dermoscopy, biopsy or in-person examination. It sits alongside other tools such as our ABCDE mole tracking workflow and full body mole mapping guidance.
Why do solo dermatologists and small clinics need affordable mole mapping?
Enterprise total body photography systems and per-provider mole mapping platforms are typically priced for large dermatology groups, with hardware, multi-seat licensing and integration contracts attached. That model can make it difficult for solo dermatologists and small practices to offer structured lesion-tracking to their patients. ScanSkinAI is designed to close that gap: AI-assisted mole mapping is bundled into the AI dermatology software Derm Starter plan at a flat US$599 per year, with no monthly billing and no per-provider fee.
What can you do with ScanSkinAI's 3D MoleMap?
- Plot lesions on Front, Back, Left and Right body views
- Switch between Skin, Regions and Mesh views
- Use male or female 3D meshes
- Link each lesion marker to a dermoscopy image and notes
- Maintain a per-lesion timeline and history
- Compare current and previous images side-by-side at follow-up
- Track AI-assisted change indicators across visits
- Hand off cases for online dermatologist review
The 3D MoleMap is designed to support — not replace — a clinician's own observations and may be paired with our chronic skin condition tracker for longitudinal cases.
How does AI assist mole mapping?
The AI layer can support lesion screening and change comparison: surfacing lesions on uploaded images, flagging visible change against previous photos, and helping reviewers prioritise their queue. It is an assistive layer within a clinician-led workflow. Final assessment, suspicion of malignancy and any recommendation for biopsy or specialist referral remain with the reviewing dermatologist. Patients who want to understand the screening side can also explore our consumer-facing melanoma checker.
Who is it for?
- Solo dermatologists
- Independent skin specialists
- Small dermatology practices
- Clinicians adding remote monitoring to existing patients
- Practices building an AI-assisted lesion-tracking workflow
Patients searching for a clinician can be referred to our find a dermatologist directory, while larger groups can review business solutions for additional B2B options.
What are the limitations?
- Cannot diagnose skin cancer, melanoma or any disease.
- Does not replace dermoscopy, biopsy or in-person clinical examination.
- AI is an assistive layer that supports — and does not replace — clinical judgement.
- Image quality (focus, lighting, framing) materially affects what the AI can surface.
- Not a medical device for autonomous diagnosis; clinician sign-off is required.